等待开盘 11-20 09:30:00 美东时间
-0.029
-3.98%
Anavex Life Sciences ( ($AVXL) ) has provided an announcement. On November 1, 2...
11-03 21:51
Anavex Life Sciences ( ($AVXL) ) has provided an update. On October 28, 2026, J...
11-03 06:25
Anavex Life Sciences ( ($AVXL) ) has issued an announcement. On October 20, 202...
10-21 04:52
Anavex Life Sciences Corp. (“Anavex” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system diseases with significant unmet medical needs, today announced that it has received notification from the U.S. Food and Drug Admin...
10-16 04:01
Anavex Life Sciences Corp. announced that all six of its director nominees were elected at its 2026 Annual Meeting of Stockholders. The newly elected Board includes Dr. Jiong Ma, Dr. Peter Donhauser, Dr. Axel Paeger, Mr. Gautam Patel, Dr. Adrian Senderowicz, and Dr. Claus van der Velden. Dr. Ma, the Independent Chair, expressed gratitude to stockholders for their support and reaffirmed the Board's commitment to advancing the Company's strategy an...
09-24 14:00
Proxy advisory firm Glass Lewis said that Anavex Life Sciences (AVXL) shareholders should vote for two of PVG Asset Management director nominees, Curtis Hogue and Jason Kolbert. Glass Lewis also advi...
09-18 01:31
Crypto.com is now authorized to bring single-stock futures to the market, CEO Kris Marszalek said in a post on X. The company is working with the SEC and the CFTC to offer single-stock perps in the US...
09-17 12:00
Anavex Life Sciences ( ($AVXL) ) has shared an update. On September 9, 2026, An...
09-10 06:20
Anavex Life Sciences (AVXL) traded higher in the premarket on Friday after PVG Asset Management urged shareholders to vote in favor of its six board nominees at the neuro drug developer’s annual meeti...
09-04 21:07
Anavex Life Sciences has regained compliance with Nasdaq Listing Rule 5250(c)(1) by filing its outstanding Form 10-Qs for Q2 and Q3 2026. The company's stock will continue trading on the Nasdaq Global Select Market under "AVXL." Anavex focuses on developing innovative CNS disease treatments and remains committed to advancing its clinical development strategy.
09-02 20:00